BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv6.6.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.biomed.cas.cz
X-WR-CALDESC:Akce na 
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Prague
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261102
DTEND;VALUE=DATE:20261114
DTSTAMP:20261106T025726
CREATED:20260916T055743Z
LAST-MODIFIED:20260916T055743Z
UID:2565-1793577600-1794614399@www.biomed.cas.cz
SUMMARY:Seminar course Advances in Molecular Biology and Genetics
DESCRIPTION:Dear colleagues\, \n\nI would like to invite you to register online for the seminar course Advances in Molecular Biology and Genetics and share news concerning the course. The program of the 50th course is available here:\n\nhttps://pokroky.img.cas.cz/programme/\n\nThe course is a two week lecture series and is particularly suitable for individual study plans (ISPs) of the first year PhD students in biomedicine as lectures cover broad area of molecular biology and biomedical research. The course is accredited at the Charles University as MPGS0034 (https://is.cuni.cz/studium/eng/predmety/index.php?do=predmet&kod=MPGS0034). Therefore\, attending the seminar course is recognized as a fulfilled study requirement in PhD programs in biomedicine at the Charles University. In the past\, some students came from the University of Chemistry and Technology (VSCHT) and the Czech University of Life Sciences (CZU). The course is held in English and will take place in Hasek lecture hall at IMG from November 2nd until 13th\, 2026.\n\nFor attending the course\, we kindly ask all participants to register at the site of the course:\n\nhttps://event.img.cas.cz/registration/advances2025/\n\nThe course is for free\, i.e. there is no registration fee. Please\, note that this registration is in addition to the course registrations/recordings at universities in PhD programs. It is for us and it is necessary\, so we can have a list of all attending students before the meeting starts. Then we can make sure that there is enough cakes during coffee breaks and can keep track of attendance\, which is needed for the credit.\n\nFurther details can be found at the website of the course: https://pokroky.img.cas.cz/\n\nIf you have any questions\, please\, contact: pokroky@img.cas.cz\n\nWith kind regards \nPetr Svoboda & Jiri Jonak on behalf of the organizing team
URL:https://www.biomed.cas.cz/event/seminar-course-advances-in-molecular-biology-and-genetics/
LOCATION:Posluchárna Milana Haška / Milan Hašek Auditorium
ORGANIZER;CN="%C3%9AMG":MAILTO:leona.krausova@img.cas.cz
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Prague:20261104T150000
DTEND;TZID=Europe/Prague:20261104T160000
DTSTAMP:20261106T025726
CREATED:20261029T104907Z
LAST-MODIFIED:20261029T104907Z
UID:2586-1793804400-1793808000@www.biomed.cas.cz
SUMMARY:Seminar Dominika Maurencová
DESCRIPTION:“Cellular senescence escape and antiviral response discriminate glioblastoma from lower-grade gliomas” \nOver the past decades\, therapeutic advancements have yielded only marginal improvements in glioblastoma (GB) patient outcomes\, with overall survival remaining limited. Senescent cells (SCs) promote the malignant progression of GB and negatively affect survival. However\, the molecular mechanisms by which they contribute to GB pathogenesis remain poorly understood. Evaluating the role of SCs in human diseases\, including cancer\, requires a multifaceted approach. Our integrative multi‑omics strategy confirmed the presence of SCs in GB patient samples\, moreover\, it revealed cells escaping senescence and active herpesvirus reactivation as possible drivers of GB aggressiveness. At the same time\, the data suggests that both processes\, senescence escape and viral infection/reactivation\, could be functionally linked. Our data confirms that primary and secondary temozolomide-induced SCs share similar features. Thus\, GB-associated SCs are ideal candidates for the development of more aggressive recurrent tumors. Overall\, our integrative approach suggests that senolytics and antivirotics are potential novel therapeutic avenues.
URL:https://www.biomed.cas.cz/event/seminar-dominika-maurencova/
LOCATION:Posluchárna Milana Haška / Milan Hašek Auditorium
ORGANIZER;CN="%C3%9AMG":MAILTO:leona.krausova@img.cas.cz
END:VEVENT
END:VCALENDAR